HYG vs IBB

iShares iBoxx High Yield Corporate Bond ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.49% for HYG.
  • HYG pays a higher dividend yield (5.90%).

Side-by-side metrics

MetricHYGIBB
Expense ratio
Annual fee. Lower is better.
0.49%0.44%
Dividend yield
Trailing 12-month yield.
5.90%0.22%
AUM
Assets under management — bigger funds are typically more liquid.
$17.63B$9.09B
YTD return
1.76%16.44%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.660.69
P/E ratio
10.9724.89
Last price
$79.75$197.34
Inception
Issuer
iSharesiShares

HYG top holdings

Top holdings · HYG
XTSLABlackRock Cash Funds Treasury SL Agency0.84%
Sector breakdown · HYG
Real Estate0.4%
Utilities99.6%

IBB top holdings

Top holdings · IBB
VRTXVertex Pharmaceuticals Inc8.07%
AMGNAmgen Inc7.82%
GILDGilead Sciences Inc6.83%
REGNRegeneron Pharmaceuticals Inc4.90%
ARGXargenx SE ADR3.75%
ALNYAlnylam Pharmaceuticals Inc3.12%
NTRANatera Inc2.89%
RVMDRevolution Medicines Inc Ordinary Shares2.78%
BIIBBiogen Inc2.46%
ILMNIllumina Inc2.07%
Sector breakdown · IBB
Healthcare100.0%

About HYG

HYG (iShares iBoxx High Yield Corporate Bond ETF) is US high-yield corporate bonds. Managed by iShares, the fund carries $17.6B in assets under management, an expense ratio of 0.49%, a dividend yield of 5.90%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 0.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.4%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.